Transdermal Therapeutics is a compound pharmacy committed to providing prescribers the highest quality customized pain management medications for their patients. It is our vision to continue providing effective non addictive pain solutions for patients and prescribers. In addition, we are partnering with the medical community through focused research and discovery of additional solutions for patients who suffer with debilitating pain, while maintaining a safe, cost effective treatment option.
Looking for a particular Transdermal Therapeutics employee's phone or email?
The Transdermal Therapeutics annual revenue was $15.7 million in 2026.
Bill Miller is the COO of Transdermal Therapeutics.
28 people are employed at Transdermal Therapeutics.
Transdermal Therapeutics is based in Birmingham, Alabama.
The NAICS codes for Transdermal Therapeutics are [4461, 45, 44, 456, 446].
The SIC codes for Transdermal Therapeutics are [283, 80, 28].